No Result

View All Result

No products in the cart.

Home Tag blood cancer

Tag: blood cancer

Surgical site anesthetic infusion may enhance analgesia after mastectomy

Quizartinib improves overall median survival in patients with acute myeloid leukemia

byNeel Mistryand1 others

May 25, 2023

1. Overall survival in the quizartinib group was 31.9 months compared to 15.1 months in the placebo group. 2. Proportion ...

#VisualAbstract: Carfilzomib, dexamethasone, and lenalidomide superior to lenalidomide monotherapy for multiple myeloma

byTeddy Guo

April 5, 2023

Click to read this study in The Lancet Oncology.

JAK2 and TET2 mutations temporally linked with myeloproliferative disorder outcomes

Momelotinib reduces symptom burden compared to danazol in patients with myelofibrosis

byJessie Willisand1 others

February 8, 2023

1. After a 24-week treatment period, a significantly greater proportion of patients randomized to momelotinib had symptom scores reduced by ...

#VisualAbstract Obinutuzumab plus lenalidomide is an active and safe therapy in advanced, previously untreated follicular lymphoma

byKathleen Lau

December 31, 2021

#VisualAbstract An ixazomib-based regimen may be a better-tolerated approach in elderly patients with newly diagnosed multiple myeloma

byKathleen Lau

December 18, 2021

$#VisualAbstract Polatuzumab vedotin plus obinutuzumab and lenalidomide shows high complete response rates in patients with relapsed or refractory follicular lymphoma$

#VisualAbstract Polatuzumab vedotin plus obinutuzumab and lenalidomide shows high complete response rates in patients with relapsed or refractory follicular lymphoma

byKathleen Lau

December 2, 2021

#VisualAbstract Intensive chemotherapy is associated with better long-term survival in older patients with acute myeloid leukemia

byKathleen Lau

November 27, 2021

#VisualAbstract In a Netherlands cohort, early mortality decreased in patients with multiple myeloma from 1999 onwards

byKathleen Lau

November 19, 2021

#VisualAbstract Lenalidomide in combination with R-CHOP is effective in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma

byKathleen Lau

November 12, 2021

#VisualAbstract Acalabrutinib monotherapy has acceptable tolerability and limited response in patients with Richter transformation

byKathleen Lau

November 11, 2021

Page 1 of 7 1 2 … 7 Next

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

Tag: blood cancer

Quizartinib improves overall median survival in patients with acute myeloid leukemia

#VisualAbstract: Carfilzomib, dexamethasone, and lenalidomide superior to lenalidomide monotherapy for multiple myeloma

Momelotinib reduces symptom burden compared to danazol in patients with myelofibrosis

#VisualAbstract Obinutuzumab plus lenalidomide is an active and safe therapy in advanced, previously untreated follicular lymphoma

#VisualAbstract An ixazomib-based regimen may be a better-tolerated approach in elderly patients with newly diagnosed multiple myeloma

#VisualAbstract Polatuzumab vedotin plus obinutuzumab and lenalidomide shows high complete response rates in patients with relapsed or refractory follicular lymphoma

#VisualAbstract Intensive chemotherapy is associated with better long-term survival in older patients with acute myeloid leukemia

#VisualAbstract In a Netherlands cohort, early mortality decreased in patients with multiple myeloma from 1999 onwards

#VisualAbstract Lenalidomide in combination with R-CHOP is effective in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma

#VisualAbstract Acalabrutinib monotherapy has acceptable tolerability and limited response in patients with Richter transformation

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports